In overweight or obese subjects, IER (60 - 85 % ER / alternate days) have been shown to produce an
average weight loss of between -5 and -8 % body - weight in studies of four to 12 weeks duration with the degree of weight - loss seemingly correlated to the length of the intervention.37, 38, 40, 45 - 47, 49 - 52 Weight - loss is accompanied by reductions in whole - body adiposity 37, 38, 40, 45 - 47, 49 - 52, waist circumference39, 40, 43, 45 and favourable shifts in adipokine expression encompassing lowered circulating levels of TNF - a 37, IL - 6 37, resistin 39, 49 and augmented adiponectin expression 39, consistent with favourable modulations in adipose fun
weight loss of between -5 and -8 % body -
weight in studies of four to 12 weeks duration with the degree of weight - loss seemingly correlated to the length of the intervention.37, 38, 40, 45 - 47, 49 - 52 Weight - loss is accompanied by reductions in whole - body adiposity 37, 38, 40, 45 - 47, 49 - 52, waist circumference39, 40, 43, 45 and favourable shifts in adipokine expression encompassing lowered circulating levels of TNF - a 37, IL - 6 37, resistin 39, 49 and augmented adiponectin expression 39, consistent with favourable modulations in adipose fun
weight in studies of four to 12 weeks
duration with the degree of
weight - loss seemingly correlated to the length of the intervention.37, 38, 40, 45 - 47, 49 - 52 Weight - loss is accompanied by reductions in whole - body adiposity 37, 38, 40, 45 - 47, 49 - 52, waist circumference39, 40, 43, 45 and favourable shifts in adipokine expression encompassing lowered circulating levels of TNF - a 37, IL - 6 37, resistin 39, 49 and augmented adiponectin expression 39, consistent with favourable modulations in adipose fun
weight - loss seemingly correlated to the length of the intervention.37, 38, 40, 45 - 47, 49 - 52
Weight - loss is accompanied by reductions in whole - body adiposity 37, 38, 40, 45 - 47, 49 - 52, waist circumference39, 40, 43, 45 and favourable shifts in adipokine expression encompassing lowered circulating levels of TNF - a 37, IL - 6 37, resistin 39, 49 and augmented adiponectin expression 39, consistent with favourable modulations in adipose fun
Weight - loss is accompanied by reductions in whole - body adiposity 37, 38, 40, 45 - 47, 49 - 52, waist circumference39, 40, 43, 45 and favourable shifts in adipokine expression encompassing lowered circulating levels of TNF - a 37, IL - 6 37, resistin 39, 49 and augmented adiponectin expression 39, consistent with favourable modulations in adipose function.